Cybin Files an International Patent Application Further Strengthening its Psychedelic Derivative Drug Development… May 26, 2021
Cybin Files its 12th Patent Further Strengthening IP Portfolio of Novel Psychedelic Molecules and Delivery Mechanisms May 20, 2021
Dr. Joel Raskin, a leader in psychiatry and neuroscience drug development, joins MINDCURE as Chief Medical Officer May 20, 2021
PharmaDrug Signs Supply Agreement With European Cannabis Extractor For Medical Grade THC Oil To Be Sold Under PharmaDrug… May 14, 2021
MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development May 13, 2021